Unknown

Dataset Information

0

COVID-19: an unexpected indication for anti-rheumatic therapies?

ABSTRACT:

SUBMITTER: Lucchino B 

PROVIDER: S-EPMC7239095 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

COVID-19: an unexpected indication for anti-rheumatic therapies?

Lucchino Bruno B   Di Franco Manuela M   Conti Fabrizio F  

Rheumatology (Oxford, England) 20200601 6

Similar Datasets

Unknown The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.
| S-EPMC7164894 | biostudies-literature
Unknown Managing rheumatic diseases during COVID-19.
| S-EPMC7476772 | biostudies-literature
Unknown COVID-19 vaccine uptake and vaccine hesitancy in rheumatic disease patients receiving immunomodulatory therapies in community practice settings.
| S-EPMC9011772 | biostudies-literature
Unknown Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19.
| S-EPMC7667946 | biostudies-literature
Unknown COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature.
| S-EPMC7239789 | biostudies-literature
Unknown Expecting the unexpected with COVID-19 vaccines.
| S-EPMC7833571 | biostudies-literature
Unknown COVID-19 in Rheumatic Diseases: A Research Agenda.
| S-EPMC7404938 | biostudies-literature
Unknown COVID-19 Among Patients With Inflammatory Rheumatic Diseases.
| S-EPMC8086428 | biostudies-literature
Unknown Anti-SARS-CoV-2 and anti-cytokine storm neutralizing antibody therapies against COVID-19: Update, challenges, and perspectives.
| S-EPMC8330556 | biostudies-literature
Unknown Pharmacogenomics of COVID-19 therapies.
| S-EPMC7435176 | biostudies-literature